Search - tctmd.com

Displaying 681 - 700 of 1463

Sort: Relevancy | Date

COVID-19: TCTMD’s Dispatch for November Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 1

November 01, 2021

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

News Daily News

New Chest Pain Guidelines Out at Last: Most Tests Have a Role

Michael O'Riordan

October 28, 2021

Polygenic Risk Score IDs People at Risk for Early MI, Death

News Daily News

Polygenic Risk Score IDs People at Risk for Early MI, Death

October 26, 2021

COVID-19: TCTMD’s Dispatch for October Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

October 25, 2021

Could a Coronary Calcium Test Rule Out CAD in Chest Pain?

News Daily News

Could a Coronary Calcium Test Rule Out CAD in Chest Pain?

Michael O'Riordan

October 21, 2021

Starting DOACs Early After Ischemic Stroke Appears Safe

News Daily News

Starting DOACs Early After Ischemic Stroke Appears Safe

October 21, 2021

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

News Daily News

As Amyloidosis Field Explodes, Physicians Need to Spot and Treat

October 20, 2021

Higher CV Mortality Among More Socially Vulnerable US Adults

News Daily News

Higher CV Mortality Among More Socially Vulnerable US Adults

Yael L. Maxwell

October 20, 2021

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

News Conference News TCT 2021

No Harm From Thrombolytics in SCAD Patients With STEMI

Michael O'Riordan

October 13, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines

News Daily News

Studies Highlight Rarity of Myocarditis With mRNA COVID-19 Vaccines

October 06, 2021

Social Determinants of Health Drive Racial CVD Risk Differences

News Daily News

Social Determinants of Health Drive Racial CVD Risk Differences

Yael L. Maxwell

October 06, 2021

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

TCTMD’s Top 10 Most Popular Stories for September 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

October 01, 2021

Women Stand to Gain the Most From Standardized STEMI Protocols

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

Survey Addresses Cardiac Rehab Challenges and Future Directions

News Daily News

Survey Addresses Cardiac Rehab Challenges and Future Directions

September 27, 2021

FDA Investigating Possible Sex Differences in LAAO Outcomes

News Daily News

FDA Investigating Possible Sex Differences in LAAO Outcomes

September 27, 2021

COVID-19: TCTMD’s Dispatch for September Week 5

News Daily News

COVID-19: TCTMD’s Dispatch for September Week 5

September 27, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.